Dongling Zou

10PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsOncology and carcinogenesis not elsewhere classifiedCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 01, 2026
An organoid-guided platform for ovarian cancer: enabling prediction of patients' chemotherapy response.

|Jul 04, 2025
Risk factors associated with overall survival in patients with cervical cancer: a prospective cohort study in Western China comparing random survival forest and Cox proportional hazards models.

Zejia Mao, Ling Long, Li Yuan

|Oct 11, 2024
Bevacizumab combined with chemotherapy could be superior to chemotherapy alone in relapsed ovarian cancer after PARPi: evidence from a multi-center propensity score-matched analysis.

Lin Zhong, Haixia Wang, Cuirong Lei

|May 06, 2024
Genetic analysis of cervical cancer with lymph node metastasis.

Hao He, Misi He, Qi Zhou

|Feb 06, 2024
Advances in ATM, ATR, WEE1, and CHK1/2 inhibitors in the treatment of PARP inhibitor-resistant ovarian cancer.

Qin Tang, Xin Wang, Haixia Wang

|Jan 22, 2024
Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers.

Yi Wang, Misi He, Tiancong He

Pageof 2

Frequent Collaborators

3 joint publications

Misi He

2 joint publications

Qi Zhou

2 joint publications

Ying Tang

2 joint publications

Lin Zhong